Consistent with this hypothesis, Day and colleagues found that PTEN mutations, identified in about 6% out of 744 stage I-IV CRC, were associated with mucinous histology, MSI, CpG island methylator phenotype, and BRAF mutations (22). Here, BRAF is linked to colorectal carcinoma.